| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Infection and Immunity, July 2008, p. 2843-2851, Vol. 76, No. 7
0019-9567/08/$08.00+0 doi:10.1128/IAI.01664-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Immunology,1 Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-2605,2 Veterans Affairs Tennessee Valley Healthcare System, Nashville, Tennessee 37212,3 Department of Microbiology and Institute for Genomic Biology, University of Illinois, Urbana, Illinois 618014
Received 13 December 2007/ Returned for modification 17 January 2008/ Accepted 23 April 2008
Helicobacter pylori VacA is a secreted pore-forming toxin that is comprised of two domains, designated p33 and p55. The p55 domain has an important role in the binding of VacA to eukaryotic cell surfaces. A total of 111 residues at the amino terminus of p55 (residues 312 to 422) are essential for the intracellular activity of VacA, which suggests that this region may constitute a subdomain with an activity distinct from cell binding. To investigate the properties of this subdomain, a small deletion mutation (targeting aspartic acid 346 and glycine 347) was introduced into the H. pylori chromosomal vacA gene. Similar to wild-type VacA, the VacA
346-347 mutant protein was proteolytically processed, secreted, and bound to eukaryotic cells. However, VacA
346-347 did not cause cell vacuolation or membrane depolarization, and it was impaired in the ability to assemble into large water-soluble oligomeric structures. Interestingly, VacA
346-347 was able to physically interact with wild-type VacA to form mixed oligomeric complexes, and VacA
346-347 inhibited wild-type vacuolating activity in a dominant-negative manner. These data indicate that the assembly of functional oligomeric VacA complexes is dependent on specific sequences, including amino acids 346 and 347, within the p55 amino-terminal subdomain.
Published ahead of print on 28 April 2008.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|